Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | REN | P00797 | 3/20 | 0.58 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.55 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.55 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.55 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6516908 | 1.00 | REN (0.58) | RENOPRM1OPRD1OPRK1SLC6A2 | |
| SCHEMBL30480493 | 0.92 | OPRM1 (0.55) | RENOPRM1OPRD1OPRK1SLC6A2 | |
| SCHEMBL30480492 | 0.92 | OPRM1 (0.55) | RENOPRM1OPRD1OPRK1SLC6A2 | |
| SCHEMBL30454361 | 0.92 | REN (0.51) | RENOPRM1OPRD1OPRK1SLC6A2 | |
| SCHEMBL31072130 | 0.91 | REN (0.46) | RENOPRM1 | |
| SCHEMBL29649768 | 0.91 | OPRM1 (0.54) | RENOPRM1OPRD1OPRK1SLC6A2 | |
| SCHEMBL31108671 | 0.91 | REN (0.55) | RENOPRM1OPRD1OPRK1SLC6A2 | |
| SCHEMBL31206334 | 0.90 | APLNR (0.59) | RENOPRM1OPRD1OPRK1 | |
| SCHEMBL29448209 | 0.90 | REN (0.66) | REN | |
| SCHEMBL11092435 | 0.90 | REN (0.47) | RENSLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260042811-A1 | NOVEL PEPTIDE HORMONE ANALOGUES | IP2IPO INNOVATIONS LTD (GB) | 2026-02-12 | — | — | US | disclosed |
| US-12516095-B2 | Peptide hormone analogues | IP2IPO INNOVATIONS LIMITED (GB) | 2026-01-06 | — | — | US | disclosed |
| US-12497438-B2 | Compounds | IP2IPO INNOVATIONS LIMITED (GB) | 2025-12-16 | — | — | US | disclosed |
| US-20250368710-A1 | NOVEL COMPOUNDS | IP2IPO INNOVATIONS LTD (GB) | 2025-12-04 | — | — | US | disclosed |
| EP-4622672-A1 | AMYLIN ANALOGUES | IP2IPO Innovations Limited (GB) | 2025-10-01 | — | — | EP | disclosed |
| CN-114450300-B | Novel compounds | IP2IPO创新有限公司 | 2025-05-20 | — | — | CN | disclosed |
| EP-3720873-B1 | GLUCAGON-LIKE PEPTIDES | IP2IPO INNOVATIONS LTD (GB) | 2024-12-04 | — | — | EP | disclosed |
| US-20240336669-A1 | NOVEL COMPOUNDS | IP2IPO INNOVATIONS LIMITED (GB) | 2024-10-10 | — | — | US | disclosed |
| WO-2024175930-A1 | COMPOUNDS | IP2IPO INNOVATIONS LIMITED (GB) | 2024-08-29 | — | — | WO | disclosed |
| WO-2024110763-A1 | AMYLIN ANALOGUES | IP2IPO INNOVATIONS LIMITED (GB) | 2024-05-30 | — | — | WO | disclosed |
| EP-4259646-A1 | NOVEL COMPOUNDS | IP2IPO Innovations Limited (GB) | 2023-10-18 | — | — | EP | disclosed |
| US-11591380-B2 | Glucagon-like peptides | IP2IPO INNOVATIONS LIMITED (GB) | 2023-02-28 | — | — | US | disclosed |
| US-20220315636-A1 | NOVEL PEPTIDE HORMONE ANALOGUES | IP2IPO INNOVATIONS LIMITED (GB) | 2022-10-06 | — | — | US | disclosed |
| WO-2022123271-A1 | NOVEL COMPOUNDS | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2022-06-16 | — | — | WO | disclosed |
| CN-114450300-A | Novel compounds | IP2IPO创新有限公司 | 2022-05-06 | — | — | CN | disclosed |
| EP-3983065-A1 | NOVEL PEPTIDE HORMONE ANALOGUES | IP2IPO Innovations Limited (GB) | 2022-04-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240336669-A1 | NOVEL COMPOUNDS | GLP1R, GIPR, GPR119 | REN 487/4885OPRM1 1499/4885OPRD1 935/4885 |
| US-12497438-B2 | Compounds | GLP1R, GPR119, GIPR | REN 619/4885OPRM1 1290/4885OPRD1 1165/4885 |
| US-20220315636-A1 | NOVEL PEPTIDE HORMONE ANALOGUES | GLP1R, GIPR, GPR119 | REN 349/4885OPRM1 1500/4885OPRD1 839/4885 |
| US-20260042811-A1 | NOVEL PEPTIDE HORMONE ANALOGUES | GLP1R, GPR119, IAPP | REN 215/4885OPRM1 883/4885OPRD1 605/4885 |
| US-20250368710-A1 | NOVEL COMPOUNDS | GLP1R, GPR119, GIPR | REN 939/4885OPRM1 1406/4885OPRD1 948/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.